Haleon (NYSE:HLN) Releases Earnings Results, Misses Estimates By $0.01 EPS

Haleon (NYSE:HLN) released its quarterly earnings results on Thursday. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01), Zacks reports. Haleon had a net margin of 9.71% and a return on equity of 19.85%. The business had revenue of $3.50 billion for the quarter, compared to the consensus estimate of $3.55 billion. During the same quarter in the prior year, the business posted $0.08 EPS.

Haleon Stock Performance

NYSE HLN traded up $0.30 during midday trading on Friday, hitting $9.63. The company had a trading volume of 6,995,874 shares, compared to its average volume of 4,408,089. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The stock has a market cap of $43.97 billion, a price-to-earnings ratio of 32.10, a P/E/G ratio of 2.69 and a beta of 0.24. The firm has a fifty day simple moving average of $8.65 and a two-hundred day simple moving average of $8.43. Haleon has a fifty-two week low of $7.70 and a fifty-two week high of $9.73.

Haleon Cuts Dividend

The business also recently declared a semi-annual dividend, which will be paid on Thursday, September 19th. Shareholders of record on Friday, August 16th will be given a $0.0514 dividend. The ex-dividend date is Friday, August 16th. This represents a yield of 1.6%. Haleon’s dividend payout ratio is 70.00%.

Wall Street Analyst Weigh In

HLN has been the topic of a number of research analyst reports. HSBC initiated coverage on shares of Haleon in a research note on Wednesday, April 17th. They issued a “buy” rating on the stock. Berenberg Bank initiated coverage on shares of Haleon in a research note on Wednesday, June 5th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.